Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial
| Autor: | Blohmer, J.-U., Schmid, P. *, Hilfrich, J., Friese, K., Kleine-Tebbe, A., Koelbl, H., Sommer, H., Morack, G., Wischnewsky, M.B., Lichtenegger, W., Kuemmel, S. |
|---|---|
| Zdroj: | In Annals of Oncology July 2010 21(7):1430-1435 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|